MyDx

MyDx, a handheld analyzer that correlates chemical composition & feeling in cannabis, to enable personalized medicine for everyone

  • Stage Product In Development
  • Industry Consumer Products
  • Location San Diego, CA, USA
  • Currency USD
  • Website mydx.me

Company Summary

Our goal is to empower the entire industry with the ability to correlate the chemical composition of cannabis with feeling in order to create a better user experience. When presented with a sample of cannabis, MyDx will be able to identify the unique strain and make a recommendation on the feeling it should create. With MyDx, you will be able to track how each strain affects you and create a chemical profile that defines your ideal strain.

Team

  • Daniel Yazbeck leverages his 10+ years of product development experience from Pfizer & Panasonic to support the execution of the MyDx plan at every level. Mr. Yazbeck is also a serial investor & entrepreneur with a focus on identifying promising start-up companies and helping them grow through the Yazbeck Consulting & Investments Group.

  • Skip Sanzeri
    Investor Relations

    Over 100 Startups

Advisors

  • Stubbs, Alderton & Markiles, LLP
    Lawyer
    Unconfirmed
    Wilson Sonsini Goodrich & Rosati
    Securities Law Firm
    Unconfirmed

Previous Investors

  • Yazbeck Consulting & Investments Group
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free